L92.8
Other granulomatous disorders of the skin and subcutaneous tissue
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code L92.8 covers a group of rare skin conditions characterized by the formation of granulomas—small areas of inflammation—within the skin and underlying subcutaneous tissue. These disorders are diverse and can arise from various causes, leading to localized skin abnormalities. Recognizing and understanding these conditions is essential for appropriate diagnosis and management. This guide provides an overview of these granulomatous skin disorders, their causes, symptoms, diagnostic approaches, and general treatment considerations.
Causes & Symptoms
Clinical Causes: Foreign body reactions, such as response to tattoo ink or other implanted materials Infections, including bacterial, fungal, or parasitic agents that induce granuloma formation Exposure to certain medications that can trigger granulomatous inflammation Autoimmune conditions where the immune system mistakenly targets skin tissues Persistent inflammatory skin conditions that evolve into granulomatous responses Unknown or idiopathic reasons in some cases where no clear causative factor is identified
Key Symptoms: Firm, raised skin lesions that may be nodular or plaque-like Localized swelling or induration (hardening) of the affected areas Colors that vary, including erythema (redness), brown, or skin-colored patches Possible skin ulceration or breakdown in chronic cases Discomfort or mild pain in affected regions, although some cases are asymptomatic Presence of multiple lesions that may cluster or spread gradually Chronically inflamed areas with potential for scarring or skin discoloration
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical evaluation, including a detailed patient history and physical examination of skin lesions. A skin biopsy is often necessary to confirm the presence of granulomatous inflammation and to rule out other skin disorders. Laboratory tests or imaging studies may be performed to identify underlying infectious or systemic causes. Histological analysis typically reveals granuloma formation, which helps distinguish these disorders from other skin conditions.
Treatment Protocols: Topical corticosteroids to reduce inflammation in localized lesions Systemic medications such as corticosteroids or immunosuppressants for more extensive or severe cases Antibiotics or antifungal agents if an infectious etiology is identified Removal of foreign bodies or irritants when applicable Addressing underlying systemic conditions that may contribute to granuloma formation Regular follow-up to monitor lesion progression and response to therapy
Clinical Advice & FAQs
Billing Guidance
Is L92.8 a billable ICD-10 code?
Yes, L92.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L92.8?
Clinical documentation must specify the nature of Other granulomatous disorders of the skin and subcutaneous tissue and any associated comorbidities for accurate reporting.
Cite this Clinical Reference